Regentis Biomaterials

GelrinC Mechanism of Action

GelrinC is an acellular biodegradable implant designed to treat focal cartilage defects and aid cartilage regeneration. GelrinC is composed of a finely-tuned combination of polyethylene glycol di-acrylate (PEG-DA) and denatured fibrinogen, crosslinked with UVA light in-situ. This results in a dense hydrogel matrix that prevents the uncontrolled infiltration of mesenchymal stem cells (MSCs) into the defect and the formation of fibrous tissue as typically is observed after a microfracture procedure.  As the GelrinC implant degrades, it is replaced by regenerated cartilage.

The key principles of the GelrinC Mode of Action have been demonstrated by in-vitro and in-vivo studies. 

  1. Complete filling and physical support
  2. Degradation occurs on implant surface
  3. Cartilage regeneration

 

 

 

 

Caution: Investigational Device. Limited by U.S. law to investigational use.